Spectrum Clinical Research Private Limited

Provides clinical research services in various medical fields, incorporated in 2006 and based in Mumbai.

2006 | Mumbai, Maharashtra (India) | Active
Last Updated: January 13, 2025

Spectrum Clinical Research Profile

Key Indicators

  • Authorised Capital ₹ 2.00 M
  • Paid Up Capital ₹ 1.00 M
  • Company Age 18 Year, 8 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 4.95 M
  • Satisfied Charges ₹ 8.53 M
  • Revenue Growth -57.25%
  • Profit Growth -191.20%
  • Ebitda -161.49%
  • Net Worth -176.73%
  • Total Assets -2.87%

About Spectrum Clinical Research

Spectrum Clinical Research Private Limited (SCRPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 22 June 2006 and has a history of 18 years and eight months. Its registered office is in Mumbai, Maharashtra, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.00 M.

The company currently has active open charges totaling ₹4.95 M. The company has closed loans amounting to ₹8.53 M, as per Ministry of Corporate Affairs (MCA) records.

Vimal Gadhiya and Viral Shah serve as directors at the Company.

Company Details

  • Location

    Mumbai, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    spectrumcr.com

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U73200MH2006PTC162777

  • Company No.

    162777

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    22 Jun 2006

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Pharma

What products or services does Spectrum Clinical Research Private Limited offer?

Spectrum Clinical Research Private Limited offers a wide range of products and services, including Pharma & Bioanalytical Services, Pharmaceutical Services.

Who are the key members and board of directors at Spectrum Clinical Research?

Board Members (2)

NameDesignationAppointment DateStatus
Vimal Gadhiya Country flag representing In Director 16-Aug-2023Current
Viral Shah Country flag representing In Additional Director 12-Feb-2022Current

Financial Performance of Spectrum Clinical Research.

Spectrum Clinical Research Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 57.25% decrease. The company also saw a substantial fall in profitability, with a 191.2% decrease in profit. The company's net worth observed a substantial decline by a decrease of 176.73%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-57.25%
Revenue from Operations
-57.73%
Total Assets
-2.87%
Profit or Loss
-191.20%
Net Worth
-176.73%
EBITDA
-161.49%

What is the Ownership and Shareholding Structure of Spectrum Clinical Research?

Unlock access to Spectrum Clinical Research's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹4.95 M

Satisfied Charges

₹8.53 M

Charges Breakdown by Lending Institutions

  • Yes Bank Limited : 0.23 Cr
  • Bank Of India : 0.19 Cr
  • Others : 0.07 Cr

Latest Charge Details

DateLenderAmountStatus
27 Dec 2023Bank Of India₹1.90 MOpen
14 Jun 2022Others₹0.74 MOpen
22 Aug 2016Yes Bank Limited₹2.31 MOpen
02 May 2014Syndicate Bank₹5.00 MSatisfied
05 Feb 2014Syndicate Bank₹1.36 MSatisfied

How Many Employees Work at Spectrum Clinical Research?

Unlock and access historical data on people associated with Spectrum Clinical Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Spectrum Clinical Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spectrum Clinical Research's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Spectrum Clinical Research

Recent activity within the organization

  • Annual General Meeting

    Spectrum Clinical Research Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

    30 Sep 2024

  • Balance Sheet

    Spectrum Clinical Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.

    31 Mar 2024

  • Charges

    A charge with Bank Of India amounted to Rs. 1.90 M with Charge ID 100875608 was registered on 27 Dec 2023.

    27 Dec 2023

  • Director Appointment

    Vimal Chandubhai Gadhiya was appointed as a Director was appointed as a Director on 16 Aug 2023 & has been associated with this company since 1 year 6 months .

    16 Aug 2023

  • Charges

    A charge with Others amounted to Rs. 0.74 M with Charge ID 100581746 was registered on 14 Jun 2022.

    14 Jun 2022

  • Director Appointment

    Viral Chittaranjan Shah was appointed as a Additional Director was appointed as a Additional Director on 12 Feb 2022 & has been associated with this company since 3 years 11 days .

    12 Feb 2022

Frequently asked questions

  • Spectrum Clinical Research Private Limited was incorporated on 22 Jun 2006.

  • The authorized share capital of Spectrum Clinical Research Private Limited is ₹ 2.00 M and paid-up capital is ₹ 1.00 M.

  • Currently 2 directors are associated with Spectrum Clinical Research Private Limited.

    • Vimal Chandubhai Gadhiya
    • Viral Chittaranjan Shah
  • As per Ministry of Corporate Affairs (Mca), the registered address of Spectrum Clinical Research Private Limited is 501 5Th Floor 37 Kshamalaya, New Marine Lines India, Mumbai, Maharashtra, 400020.

  • The corporate identification number (CIN) of Spectrum Clinical Research Private Limited is U73200MH2006PTC162777 and the company number is 162777 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Spectrum Clinical Research Private Limited is https://www.spectrumcr.com

  • According to the financial reports for the fiscal year 2023, the revenue trend for Spectrum Clinical Research Private Limited has fallen by -57.25%.

  • The financial reports for the fiscal year 2023 indicates that The net worth of Spectrum Clinical Research Private Limited has experienced an downturn of -176.73%.

  • As per the financial statements for fiscal Year 2023, The total open charges for Spectrum Clinical Research Private Limited amount to ₹ 4.95 M.

  • The most recent Balance Sheet for Spectrum Clinical Research Private Limited was filed with the ROC on 31 Mar 2024.

Similar Companies Based on Pharma Contract R&D